Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan

Microbiology and Immunology

Volumn 44, Issue 10, 2000, Pages 833-839

  Masuda, Hiroki ^a,c   Suzuki, Hiroshi ^a   Oshitani, Hitoshi ^a   Saito, Reiko ^a   Kawasaki, Satoshi ^a   Nishikawa, Makoto ^b   Satoh, Hiroshi ^c  

^a NIIGATA UNIVERSITY   (Japan)

^b Niigata Prefectural Research Laboratory for Health and Environment   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Amantadine resistant; Influenza A virus; M2 protein; Nursing home

Indexed keywords

AMANTADINE; AMINO ACID; PROTEIN M 2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG INDICATION; EPIDEMIC; HEALTH SURVEY; HUMAN; INFLUENZA; INFLUENZA VIRUS A; JAPAN; NONHUMAN; NURSING HOME; VIRUS RESISTANCE;

AMANTADINE; ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; HUMAN; INCIDENCE; INFLUENZA; INFLUENZA A VIRUS, HUMAN; JAPAN; NURSING HOMES; SENTINEL SURVEILLANCE; SEQUENCE ANALYSIS, DNA; VIRAL MATRIX PROTEINS;

EID: 0033788325     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2000.tb02571.x     Document Type: Article

References (24)

1. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection
2. Resistance of influenza A virus to amantadine and rimantadine: Results of one decade of surveillance
3. Production of the M2 protein of influenza A virus in insect cells is enhanced in the presence of amantadine
4. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: A randomized controlled trial
5. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
6. Amantadine-resistant influenza A in a nursing facility
7. Children with influenza A infection; treatment with rimantadine
8. The action of adamantanamines against influenza A viruses: Inhibition of the M2 ion channel protein
9. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families
10. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine
11. Influenza A virus M2 ion channel protein: A structure-function analysis
12. Amantadine-resistant influenza A in nursing homes
13. Prolonged shedding of amantadine-resistant influenza A viruses by immunodeficient patients: Detection by polymerase chain reaction-restriction analysis
14. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2)
15. Two outbreaks of influenza A (H3N2) in a Japanese nursing home in the winter of 1996-97, with differing vaccine efficacy
16. A microplate method for isolation of viruses from infants and children with acute respiratory infections
17. Efficacy of influenza vaccine in nursing homes
18. Influenza vires M2 protein has ion channel activity
19. Amantadine susceptibility in influenza A virus isolates: Determination methods and lack of resistance in a Canadian sample, 1991-94
20. How to overcome resistance of influenza A viruses against adamantane derivatives
21. Emergence of drug resistance during an influenza epidemic: Insights from a mathematical model
22. Structural characteristics of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel
23. Ion channel activity of influenza A virus M2 protein: Characterization of the amantadine block
24. Low incidence of rimantadine resistance in field isolates of influenza A viruses